Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.

<h4>Rationale</h4>Frequent chronic obstructive pulmonary disease (COPD) exacerbations are a major cause of hospital admission and mortality and are associated with increased airway inflammation. Macrolides have airway antiinflammatory actions and may reduce the incidence of COPD exacerbations.<h4>Ob... View More